These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 593266)

  • 1. Pteridine regulation of inhibition of hepatic uroporphyrinogen L synthetase activity by lead chloride.
    Piper WN; Van Lier BL
    Mol Pharmacol; 1977 Nov; 13(6):1126-35. PubMed ID: 593266
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation of a factor that protects against lead inhibition of hepatic and erythrocytic uroporphyrinogen I synthetase activity.
    Piper WN; Van Lier RB
    Life Sci; 1976 Oct; 19(8):1225-34. PubMed ID: 994723
    [No Abstract]   [Full Text] [Related]  

  • 3. Sulfonamide inhibition of rat hepatic uroporphyrinogen I synthetase activity and the biosynthesis of heme.
    Peters PG; Sharma ML; Hardwicke DM; Piper WN
    Arch Biochem Biophys; 1980 Apr; 201(1):88-94. PubMed ID: 6893114
    [No Abstract]   [Full Text] [Related]  

  • 4. Uroporphyrinogen-I-synthetase activity in red blood cells of lead-exposed workers.
    El-Waseef A
    Acta Med Acad Sci Hung; 1982; 39(1-2):95-100. PubMed ID: 7180366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of uroporphyrinogen I synthase activity and depression of microsomal heme and cytochrome P-450 in rat liver by bilirubin.
    Kohashi M; Tse J; Piper WN
    Life Sci; 1984 Jan; 34(2):193-6. PubMed ID: 6694518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of sulfamerazine inhibition of rat hepatic uroporphyrinogen synthesis by folic acid.
    Christenson WR; Reddy VR; Piper WN
    Life Sci; 1986 May; 38(18):1679-84. PubMed ID: 3702597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibition of erythrocyte and hepatic uroporphyrinogen I synthetase activity by lead.
    Piper WN; Tephly TR
    Life Sci; 1974 Mar; 14(5):873-6. PubMed ID: 4828403
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative inhibition of hepatic hydroxymethylbilane synthase by both hard and soft metal cations.
    Farmer DJ; Hollebone BR
    Can J Biochem Cell Biol; 1984 Jan; 62(1):49-54. PubMed ID: 6732900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lead on the activity of erythrocyte porphobilinogen deaminase in vivo and in vitro.
    Tomokuni K; Ichiba M
    Toxicol Lett; 1990 Feb; 50(2-3):137-42. PubMed ID: 2309232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of lead inhibition of delta-aminolevulinic acid dehydratase by a low molecular weight, high affinity renal lead-binding protein.
    Goering PL; Fowler BA
    J Pharmacol Exp Ther; 1984 Oct; 231(1):66-71. PubMed ID: 6092606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of hydroxymethylbilane synthase (porphobilinogen deaminase) by pyridoxal 5'-phosphate. Demonstration of an essential lysine residue.
    Hart GJ; Leeper FJ; Battersby AR
    Biochem J; 1984 Aug; 222(1):93-102. PubMed ID: 6433896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontogenetic dynamics of delta-amino-laevulinic acid dehydratase activity in chick embryo organs and the changes in hepatocytes after exposure to lead.
    Cibulka J; Thomas B
    Br Poult Sci; 1982 Nov; 23(6):563-8. PubMed ID: 7165829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat hepatic uroporphyrinogen III cosynthase: purification, properties, and inhibition by metal ions.
    Clement RP; Kohashi M; Piper WN
    Arch Biochem Biophys; 1982 Apr; 214(2):657-67. PubMed ID: 7092213
    [No Abstract]   [Full Text] [Related]  

  • 14. Rat hepatic uroporphyrinogen III co-synthase. Purification and evidence for a bound folate coenzyme participating in the biosynthesis of uroporphyrinogen III.
    Kohashi M; Clement RP; Tse J; Piper WN
    Biochem J; 1984 Jun; 220(3):755-65. PubMed ID: 6466301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification by affinity chromatography and properties of uroporphyrinogen I synthetase from Chlorella regularis.
    Shioi Y; Nagamine M; Kuroki M; Sasa T
    Biochim Biophys Acta; 1980 Dec; 616(2):300-9. PubMed ID: 7213640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological effects of lead. (6). Effect of exposure on pH activity curves of hepatic and erythrocyte gamma-aminolaevulinate dehydratase].
    Tomokuni K
    Nihon Eiseigaku Zasshi; 1975 Apr; 30(1):110. PubMed ID: 237131
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence that pyridoxal phosphate modification of lysine residues (Lys-55 and Lys-59) causes inactivation of hydroxymethylbilane synthase (porphobilinogen deaminase).
    Miller AD; Packman LC; Hart GJ; Alefounder PR; Abell C; Battersby AR
    Biochem J; 1989 Aug; 262(1):119-24. PubMed ID: 2510713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Uroporphyrinogen-I-synthetase in erythrocytes in acute intermittent porphyria].
    Iwanov ED; Adjarov D; Tsanev R
    Acta Biol Med Ger; 1977; 36(5-6):801-4. PubMed ID: 602585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of free and enzyme-bound intermediates in the reaction mechanism catalyzed by the bovine liver immobilized porphobilinogen deaminase. Proof that they are substrates for cosynthetase in uroporphyrinogen III biosynthesis.
    Kotler ML; Juknat AA; Fumagalli SA; Batlle AM
    Biotechnol Appl Biochem; 1991 Apr; 13(2):173-80. PubMed ID: 2043278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A low molecular weight lead-binding protein in brain attenuates lead inhibition of delta-aminolevulinic acid dehydratase: comparison with a renal lead-binding protein.
    Goering PL; Mistry P; Fowler BA
    J Pharmacol Exp Ther; 1986 Apr; 237(1):220-5. PubMed ID: 3958965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.